Unknown NA INTERVENTIONAL 3-arm NCT00924014

Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure

Comparative Effects of Conivaptan and Loop Diuretics on Plasma Neurohormones and Systemic and Renal Hemodynamics in Subjects With Chronic Congestive Heart Failure

Sponsor: Astellas Pharma Inc

Conditions Heart Failure

Interventions Conivaptan Conivaptan and furosemide Furosemide

Updated 5 times since 2017 Last updated: Jun 17, 2009 Started: Jul 31, 2009 Primary completion: Dec 31, 2009 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00924014, this NA trial focuses on Heart Failure and remains ongoing. Sponsored by Astellas Pharma Inc, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2017 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Inc
Hennepin County Medical Center, Minneapolis

Data source: Hennepin County Medical Center, Minneapolis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States